'On consolidated basis
Quarter ended June 2024 compared
with Quarter ended March 2024.
Net sales (including other operating income) of HCL Technologies has declined
1.55% to Rs 28057 crore.
Operating profit margin has declined
from 21.46% to 20.65%, leading to 5.30% decline in operating profit to Rs
5,793.00 crore. Purchase of finished goods cost fell from 1.73% to
1.44%. Employee cost increased from 57.41% to 58.54%.
Other expenses fell from 19.38% to 19.35%. Contract job
process charges fell from 13.03% to 12.63%.
Other income rose 165.14% to Rs 1103
crore. PBIDT rose 5.56% to Rs 6896 crore. Provision for
interest rose 11.70% to Rs 191 crore.
PBDT rose 5.39% to Rs 6705
crore. Provision for depreciation fell 8.69% to Rs 998
crore.
Profit before tax grew 8.31% to Rs
5,707.00 crore. Share of profit/loss were nil in both the
periods. Provision ...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Nov-2024)
Gland Pharma
-
-
NII growth improves to 4% in Q2FY25
-
Revenue up 6.9% YoY to Rs 1064.0 cr, PAT up 4.5% YoY to Rs 307.9cr in Q2FY2025
|
|